BioSpace News Archive

Hospital for Special Surgery, the world’s leading academic medical center specialized in musculoskeletal health, and New Zealand-based medical device and technology company MARS Bioimaging Limited announced a new collaborative relationship based on MARS’s photon-counting spectral CT imaging technology.

The National Comprehensive Cancer Network® —an alliance of leading cancer centers—convened a policy summit to examine how geography impacts cancer outcomes.

CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy, announced a collaborative clinical trial grant to test repurposing of the FDA-approved drug Vyvgart, for its potential ability to reduce antibodies to adeno-associated virus in Duchenne muscular dystrophy patients.

Galapagos NV announced the appointment of Thad Huston as Chief Financial Officer and Chief Operating Officer as per 1 July 2023.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced the approval by Gorham Savings Bank and the Finance Authority of Maine of the principal terms of a $3 million debt facility with the Company.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance, announced a proposed public offering of its common stock.

AVITA Medical, Inc. announced the appointment of David O’Toole as its new Chief Financial Officer, effective June 15, 2023.

Stereotaxis announced that it intends to initiate a first-in-human trial to support the CE Mark submission for its MAGiC™ catheter.

Beyond Air, Inc., and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide for the treatment of solid tumors, announced securing a senior secured debt financing of up to $40 million from funds managed by Avenue Capital Group.

SCYNEXIS, Inc. announced that David Angulo, President and Chief Executive Officer, will take part in a fireside chat at the upcoming Maxim Group Virtual Healthcare Conference on Tuesday, June 20th at 12:30 P.M. ET.